首页 | 本学科首页   官方微博 | 高级检索  
检索        

高位恶性梗阻性黄疸胆道内支架置入治疗的临床应用
引用本文:于世平,徐克,冯博,张曦彤,苏洪英,钟红珊.高位恶性梗阻性黄疸胆道内支架置入治疗的临床应用[J].中华肝胆外科杂志,2005,11(9):612-615.
作者姓名:于世平  徐克  冯博  张曦彤  苏洪英  钟红珊
作者单位:110001,沈阳市,中国医科大学附属第一医院放射科
摘    要:目的评价高位恶性梗阻性黄疸胆道内支架置入治疗的疗效及临床价值。方法42例高位恶性梗阻性黄疸病人分别行单侧/双侧穿刺入路,充分胆道内外引流后,置入支架。其中肝总管内置入单枚支架19例;双侧肝管穿刺,行左肝和右肝胆管同时置入支架11例;采用单侧肝管穿刺入路,于左-右肝管间和肝管-胆总管间均置入支架12例。共置入支架65枚,其中3枚为覆膜支架,其余均为自膨式裸支架。结果42例病人中,手术成功率达100%,其中2例病人分别于术后4个月和9个月发生支架内梗阻,行二次介入治疗;1例病人于胆道支架置入术后17个月发生十二指肠梗阻,再行十二指肠支架置入术;1例病人于围手术期因严重胆系感染而死亡.全部病人随访3~112周(平均49周),均获得满意的减黄效果。结论根据不同梗阻部位,采用多种胆道支架置入技术治疗高位恶性梗阻性黄疸是一种安全可靠、疗效确切的姑息性疗法。

关 键 词:胆汁瘀积  恶性梗阻性黄疸  介入治疗  支架  高位恶性梗阻性黄疸  支架置入治疗  胆道内  临床应用  梗阻性黄疸病人  十二指肠梗阻
收稿时间:2004-11-21
修稿时间:2004年11月21

Clinical application of stent insertion in bile duct for malignant hilar biliary obstructive jaundice
YU Shi-ping, XU Ke, FENG Bo,et al..Clinical application of stent insertion in bile duct for malignant hilar biliary obstructive jaundice[J].Chinese Journal of Hepatobiliary Surgery,2005,11(9):612-615.
Authors:YU Shi-ping  XU Ke  FENG Bo  
Institution:YU Shi-ping, XU Ke, FENG Bo, et al.
Abstract:Objective To determine the therapeutic effect and clinical value of the stent insertion in biliary tract for treatment of malignant hilar biliary obstructive jaundice (MHBOJ). Methods A total of 42 patients with MHBOJ were treated by complete internal and external drainage of biliary tract via unilateral or bilateral hepatic duct puncture and stent insertion. Of the 42 patients, 19 received the single stent insertion in the common hepatic duct, 11 received stent insertion in both left and right hepatic bile duct via bilateral hepatic duct puncture and 12 received stent insertion between the left and right hepatic duct and between the hepatic duct and the common bile duct. Sixty-five stents including 3 coated stents and 62 self-expanding bare ones were used. Results The achievement ratio of operation was 100% in the 42 patients. Two patients suffered from obstruction in the stent in 4 and 9 months, respectively, after the operation and they received the second interventional therapy. One patient suffered from duodenal ileus in 17 months after stent insertion in the bile duct. Therefore, the stent insertion in the dodecadactylon was applied. One patient died of serious infection of biliary tree during the ambi-operation. The follow-up for 3-112 weeks (mean = 49 weeks) in all the patients showed satisfactory results. Conclusions Multiple stent insertion in the bile duct based on different location of obstruction is a safe and reliable palliative therapy with exact therapeutic effect for treatment of MHBOJ.
Keywords:Chlestasis  Malignant biliary obstructive jaundice  Interventional therapy  Stent
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号